Exactech’s (EXAC) Hold Rating Reaffirmed at Robert W. Baird
Exactech (NASDAQ:EXAC)‘s stock had its “hold” rating reiterated by analysts at Robert W. Baird in a report issued on Thursday. They presently have a $49.00 price target on the medical equipment provider’s stock. Robert W. Baird’s price objective would suggest a potential downside of 3.07% from the stock’s current price.
Other equities analysts have also recently issued reports about the stock. BidaskClub raised shares of Exactech from a “sell” rating to a “hold” rating in a research note on Friday, August 18th. ValuEngine cut shares of Exactech from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Sidoti downgraded Exactech from a “buy” rating to a “neutral” rating in a research note on Monday, October 23rd. Gabelli cut Exactech from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Finally, Zacks Investment Research cut Exactech from a “hold” rating to a “sell” rating in a report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $49.00.
Exactech (NASDAQ EXAC) opened at $50.55 on Thursday. The company has a quick ratio of 2.09, a current ratio of 4.08 and a debt-to-equity ratio of 0.06. Exactech has a 1 year low of $23.30 and a 1 year high of $50.95. The firm has a market cap of $724.99, a P/E ratio of 41.57, a PEG ratio of 4.32 and a beta of 1.02.
Several hedge funds have recently bought and sold shares of EXAC. Public Employees Retirement System of Ohio lifted its position in shares of Exactech by 36.3% in the second quarter. Public Employees Retirement System of Ohio now owns 3,740 shares of the medical equipment provider’s stock worth $100,000 after buying an additional 997 shares in the last quarter. Salem Investment Counselors Inc. bought a new stake in Exactech during the 1st quarter valued at $129,000. Bank of Montreal Can acquired a new stake in shares of Exactech in the 2nd quarter worth $134,000. Acrospire Investment Management LLC acquired a new stake in shares of Exactech in the 1st quarter worth $143,000. Finally, American International Group Inc. raised its stake in Exactech by 7.1% in the 1st quarter. American International Group Inc. now owns 6,423 shares of the medical equipment provider’s stock worth $162,000 after acquiring an additional 424 shares during the last quarter. Hedge funds and other institutional investors own 66.44% of the company’s stock.
TRADEMARK VIOLATION WARNING: This news story was published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/07/exactechs-exac-hold-rating-reaffirmed-at-robert-w-baird.html.
Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.
Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.